{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Randomized, Multicenter, Phase 3 Clinical Trial of Vusolimogene Oderparepvec in Combination with Nivolumab Versus Treatment of Physician’s Choice in Patients with Advanced Melanoma That Has Progressed on an Anti-PD-1 Containing Treatment Regimen","item":"https:\/\/www.regionalcancercare.org\/trials\/a-randomized-multicenter-phase-3-clinical-trial-of-vusolimogene-oderparepvec-in-combination-with-nivolumab-versus-treatment-of-physicians-choice-in-patients-with-advanced-melanoma-that-has-progress\/#breadcrumbitem"}]}